The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A 11C-MET PET Study.
Nijiati KudulaitiHuiwei ZhangTianming QiuJunfeng LuAbudumijiti AibaidulaZhengwei ZhangYihui GuanDongxiao ZhuangPublished in: Molecular imaging (2020)
11C-methionine PET can noninvasively evaluate the IDH1 mutation status of patients with nonenhancing supratentorial diffuse gliomas.